PLIVA FDA Approval ANDA 074026

ANDA 074026

PLIVA

FDA Drug Application

Application #074026

Application Sponsors

ANDA 074026PLIVA

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL25MG;37.5MG0TRIAMTERENE AND HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE; TRIAMTERENE

FDA Submissions

ORIG1AP1996-04-26
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2000-07-07
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2001-05-17
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2001-05-29

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL4Null0

CDER Filings

PLIVA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 74026
            [companyName] => PLIVA
            [docInserts] => ["",""]
            [products] => [{"drugName":"TRIAMTERENE AND HYDROCHLOROTHIAZIDE","activeIngredients":"HYDROCHLOROTHIAZIDE; TRIAMTERENE","strength":"25MG;37.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TRIAMTERENE AND HYDROCHLOROTHIAZIDE","submission":"HYDROCHLOROTHIAZIDE; TRIAMTERENE","actionType":"25MG;37.5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.